These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 12849885)

  • 1. Rapid infusion of sodium valproate in acutely ill children.
    Birnbaum AK; Kriel RL; Norberg SK; Wical BS; Le DN; Leppik IE; Cloyd JC
    Pediatr Neurol; 2003 Apr; 28(4):300-3. PubMed ID: 12849885
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical and pharmacokinetic observations on valproate: a 3 year follow-up study in 100 children with generalized epilepsy.
    Steinborn B; Galas-Zgorzalewicz B
    Funct Neurol; 1993; 8(6):415-22. PubMed ID: 8150320
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [A single daily dose with valproic acid. A pharmacodynamic and clinical study].
    Pelzl G; Mamoli B
    Wien Klin Wochenschr; 1992; 104(10):286-9. PubMed ID: 1604872
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Rapid infusion with valproate sodium is well tolerated in patients with epilepsy.
    Wheless JW; Vazquez BR; Kanner AM; Ramsay RE; Morton L; Pellock JM
    Neurology; 2004 Oct; 63(8):1507-8. PubMed ID: 15505177
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Add-on therapy with nimodipine in intractable epilepsy of childhood.
    Malashkhia VY; Nadareishvili ZG; Malashkhia YA
    J Child Neurol; 1996 Nov; 11(6):500-1. PubMed ID: 9120234
    [No Abstract]   [Full Text] [Related]  

  • 6. A comparison of valproate with carbamazepine for the treatment of complex partial seizures and secondarily generalized tonic-clonic seizures in adults. The Department of Veterans Affairs Epilepsy Cooperative Study No. 264 Group.
    Mattson RH; Cramer JA; Collins JF
    N Engl J Med; 1992 Sep; 327(11):765-71. PubMed ID: 1298221
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Valproate unbound fraction and distribution volume following rapid infusions in patients with epilepsy.
    Cloyd JC; Dutta S; Cao G; Walch JK; Collins SD; Granneman GR;
    Epilepsy Res; 2003 Feb; 53(1-2):19-27. PubMed ID: 12576164
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [The pharmacokinetic optimization of depakin in children with epilepsy].
    Shamansurov ShSh
    Zh Nevrol Psikhiatr Im S S Korsakova; 1994; 94(6):37-8. PubMed ID: 7740873
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Safety of rapid intravenous valproate infusion in pediatric patients.
    Morton LD; O'Hara KA; Coots BP; Pellock JM
    Pediatr Neurol; 2007 Feb; 36(2):81-3. PubMed ID: 17275657
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intravenous valproate dosing in neonates.
    Alfonso I; Alvarez LA; Gilman J; Dunoyer C; Yelin K; Papazian O
    J Child Neurol; 2000 Dec; 15(12):827-9. PubMed ID: 11198504
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Anticonvulsive pharmacotherapy may aggravate epilepsy course].
    Zenkov LR
    Zh Nevrol Psikhiatr Im S S Korsakova; 2005; 105(10):52-4. PubMed ID: 16281381
    [No Abstract]   [Full Text] [Related]  

  • 12. Steady-state pharmacokinetic simulation of intermittent vs. continuous infusion valproic acid therapy in non-critically ill and critically ill patients.
    Van Matre ET; Cook AM
    Neurol Res; 2016 Sep; 38(9):786-91. PubMed ID: 27414414
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Disabling tremor after lamotrigine with sodium valproate.
    Reutens DC; Duncan JS; Patsalos PN
    Lancet; 1993 Jul; 342(8864):185-6. PubMed ID: 8101290
    [No Abstract]   [Full Text] [Related]  

  • 14. Lamotrigine adjunctive therapy among children and adolescents with primary generalized tonic-clonic seizures.
    Trevathan E; Kerls SP; Hammer AE; Vuong A; Messenheimer JA
    Pediatrics; 2006 Aug; 118(2):e371-8. PubMed ID: 16847080
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Weight gain with valproate or carbamazepine--a reappraisal.
    Easter D; O'Bryan-Tear CG; Verity C
    Seizure; 1997 Apr; 6(2):121-5. PubMed ID: 9153724
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Low-dose sodium valproate in the treatment of idiopathic generalized epilepsies.
    Miró J; Aiguabella M; Veciana M; Juvany R; Santurino M; Leiva E; Salas-Puig J; Falip M
    Acta Neurol Scand; 2014 May; 129(5):e20-3. PubMed ID: 24372179
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacokinetics of slow-release preparations of sodium valproate.
    Yamatogi Y; Yoshinaga H; Oka E; Ohtahara S; Yamashita S; Furuno K; Gomita Y
    Psychiatry Clin Neurosci; 1995 Dec; 49(5-6):309-10. PubMed ID: 8726120
    [No Abstract]   [Full Text] [Related]  

  • 18. Pharmacokinetics and clinical application of intravenous valproate in Thai epileptic children.
    Visudtibhan A; Bhudhisawadi K; Vaewpanich J; Chulavatnatol S; Kaojareon S
    Brain Dev; 2011 Mar; 33(3):189-94. PubMed ID: 20444563
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Efficacy and safety of intravenous sodium valproate versus phenobarbital in controlling convulsive status epilepticus and acute prolonged convulsive seizures in children: a randomised trial.
    Malamiri RA; Ghaempanah M; Khosroshahi N; Nikkhah A; Bavarian B; Ashrafi MR
    Eur J Paediatr Neurol; 2012 Sep; 16(5):536-41. PubMed ID: 22326977
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Remacemide hydrochloride: a placebo-controlled, one month, double-blind assessment of its safety, tolerability and pharmacokinetics as adjunctive therapy in patients with epilepsy.
    Chadwick D; Smith D; Crawford P; Harrison B
    Seizure; 2000 Dec; 9(8):544-50. PubMed ID: 11162751
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.